Actuated Medical is proud to announce the appointment of Dr. David L. Diehl to its Medical Advisory Board. A board-certified and fellowship-trained gastroenterologist, Dr. Diehl specializes in endoscopic ultrasound, ERCP, and advanced therapeutic endoscopy. He earned his medical degree from UCLA and completed his residency at Harbor-UCLA Medical Center, followed by fellowship training at UCSF and UCLA.
Maureen L. Mulvihill, Ph.D., Actuated Medical President & CEO
Dr. Diehl is the Founder of the Advanced Endoscopy Fellowship at Geisinger is a Professor of Medicine and Pathology at the Geisinger Commonwealth School of Medicine. With over 400 publications, he is a recognized leader in gastroenterology and is dedicated to advancing patient care in his field. His extensive expertise will significantly enhance Actuated Medical’s Medical Advisory Board, supporting the company’s mission to innovate and improve patient outcomes.
“We are pleased to have Dr. Diehl join our Medical Advisory Board. With his vast expertise and passion for enhancing patient care, he is a perfect fit for our mission to develop cutting-edge healthcare solutions. We are excited to benefit from his perspectives, which will help guide our strategic efforts and further our innovation.”
— Maureen L. Mulvihill, Ph.D., Actuated Medical President & CEO
David L. Diehl, MD, M.D., FACP, FASGE
“I have enjoyed working with the Actuated Medical engineering team on several occasions and brainstorming their product designs. As a member of their Medical Advisory Board, I look forward to collaborating with them to further advance healthcare innovation and improving patient lives.”
— David L. Diehl, MD, M.D., FACP, FASGE
About
Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology.
With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs.
The company’s technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders.
Actuated holds 42 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies.
Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-
Contact
- http://actuatedmedical.com/
- Maureen L. Mulvihill, Ph.D
- 814-355-0003
- info@actuatedmedical.com
- 320 Rolling Ridge Dr., Bellefonte, PA 16823